Back to search
Non-proliferative Diabetic Retinopathy (NPDR)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Non-proliferative Diabetic Retinopathy (NPDR) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Non-proliferative Diabetic Retinopathy (NPDR) trials you may qualify forPilot, single-site, prospective study of QLS-111 0.015 % in subjects with NPDR, OAG or NTG
The goal of this clinical trial is to learn about the safety of the investigational medicinal product ANXV. It will also learn about how ANXV works to treat non…
The goal of this clinical trial is to evaluate whether remote ischemic conditioning (RIC) is a safe and effective treatment for non-proliferative diabetic retin…
The goal of this clinical trial is to evaluate the efficacy, safety, pharmacokinetics (PK) and pharmacodynamics (PD) of VX-01 as stand-alone treatment for Diabe…
The purpose of this Phase 2 study is comprised of two groups to evaluate the safety, tolerability, and efficacy of faricimab in patients with Non-Proliferative…
Phase 2 study to assess the efficacy of topically administered eyedrops of INV-102 during a 12-week dosing period in subjects with non-center involved DME (NCID…
To identify biomarkers, obtained using non-invasive procedures, that can predict disease progression and progression to sight-threatening stages of the disease…